---
schema_version: "secwatch.filing_event.v1"
accession: "0000898432-22-000319"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2022-04-29T23:59:59+00:00"
generated_at: "2026-06-26T02:30:32.050734+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# iRadimed CFO/COO Resigns; Controller Named Interim CFO

## Summary
- Chris Scott, CFO and COO, resigns effective May 27, 2022 to pursue other opportunities.
- Matt Garner, Controller, appointed interim CFO effective April 28, 2022.
- Garner to receive $50,000 bonus (grossed up to max $76,000) upon permanent CFO appointment.
- Formal search for a new CFO has commenced.

## SEC filing metadata
- accession: 0000898432-22-000319
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2022-04-29T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000319/0000898432-22-000319-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000319/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000898432-22-000319
- JSON: https://secwatch.observer/filing/0000898432-22-000319.json
- Plain text: https://secwatch.observer/filing/0000898432-22-000319.txt

## Key facts
- Executive change
  Chris Scott resigned as Chief Financial and Operating Officer at IRADIMED CORP.
  - Action: resigned
  - Role: Chief Financial and Operating Officer
  source text: announcing the resignation of Chris Scott, Chief Financial and Operating Officer of iRadimed Corporation (the “Company”), effective May 27, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000319/0000898432-22-000319-index.htm
- Executive change
  Matt Garner was appointed as interim Chief Financial Officer at IRADIMED CORP.
  - Action: appointed
  - Role: interim Chief Financial Officer
  source text: has appointed Matt Garner, Controller, to serve as interim Chief Financial Officer, effective April 28, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000319/0000898432-22-000319-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.